BDNF plasma levels decrease during benzodiazepine withdrawal in patients suffering from comorbidity of depressive disorder and benzodiazepine dependence.
Heberlein
Annemarie
A
Lenz
Bernd
B
Muschler
Marc
M
Frieling
Helge
H
Buechl
Rebecca
R
Gröschl
Michael
M
Kornhuber
Johannes
J
Bleich
Stefan
S
Hillemacher
Thomas
T
D001569:Benzodiazepines; D015415:Biomarkers; D019208:Brain-Derived Neurotrophic Factor / Q000097:blood*; D016022:Case-Control Studies; D003866:Depressive Disorder / Q000097:blood* / Q000150:complications; D015536:Down-Regulation; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000097:blood; D006801:Humans; D013375:Substance Withdrawal Syndrome / Q000097:blood* / Q000150:complications
D015415:Biomarkers; D019208:Brain-Derived Neurotrophic Factor; D051100:Glial Cell Line-Derived Neurotrophic Factor; D001569:Benzodiazepines